These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7720242)

  • 21. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic and prognostic value of ProGRP in lung cancer.
    Nisman B; Biran H; Ramu N; Heching N; Barak V; Peretz T
    Anticancer Res; 2009 Nov; 29(11):4827-32. PubMed ID: 20032442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiplexing determination of small cell lung cancer biomarkers and their isovariants in serum by immunocapture LC-MS/MS.
    Torsetnes SB; Levernæs MS; Broughton MN; Paus E; Halvorsen TG; Reubsaet L
    Anal Chem; 2014 Jul; 86(14):6983-92. PubMed ID: 24945626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and clinical validity of two immunoassays for ProGRP.
    Nordlund MS; Stieber P; Brustugun OT; Warren DJ; Paus E
    Tumour Biol; 2012 Aug; 33(4):1105-13. PubMed ID: 22399443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated progastrin-releasing peptide(31-98) concentrations in pleural effusions due to small-cell lung carcinoma.
    Shijubo N; Hirasawa M; Sasaki H; Igarashi T; Fujita A; Kodama T; Yamaguchi K; Abe S
    Respiration; 1996; 63(2):106-10. PubMed ID: 8966363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digging deeper into the field of the small cell lung cancer tumor marker ProGRP: a method for differentiation of its isoforms.
    Torsetnes SB; Nordlund MS; Paus E; Halvorsen TG; Reubsaet L
    J Proteome Res; 2013 Jan; 12(1):412-20. PubMed ID: 23190087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test.
    Muley T; Zhang X; Holdenrieder S; Korse CM; Zhi XY; Molina R; Liu Z; Hartmann G; van den Heuvel MM; Qian K; Marrades R; Engel C; He Y; Wehnl B; Dayyani F; Herth F
    Tumour Biol; 2020 Sep; 42(9):1010428320958603. PubMed ID: 32964798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
    Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
    Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability of pro-gastrin-releasing peptide in serum versus plasma.
    Yoshimura T; Fujita K; Kawakami S; Takeda K; Chan S; Beligere G; Dowell B
    Tumour Biol; 2008; 29(4):224-30. PubMed ID: 18781094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining ProGRP and isoforms in lung and thyroid cancer patient samples: comparing an MS method with a routine clinical immunoassay.
    Torsetnes SB; Broughton MN; Paus E; Halvorsen TG; Reubsaet L
    Anal Bioanal Chem; 2014 Apr; 406(11):2733-8. PubMed ID: 24518900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and Characterization of Monoclonal Antibodies for Immunoassay of the Lung Cancer Marker proGRP.
    Nordlund MS; Fermer C; Nilsson O; Warren DJ; Paus E
    Tumour Biol; 2007; 28(2):100-10. PubMed ID: 17287611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
    Ni J; Guo Z; Zhang L
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic characteristics of patients with nonsmall cell lung carcinoma with elevated serum progastrin-releasing peptide levels.
    Goto K; Kodama T; Hojo F; Kubota K; Kakinuma R; Matsumoto T; Ohmatsu H; Sekine I; Nagai K; Nishiwaki Y
    Cancer; 1998 Mar; 82(6):1056-61. PubMed ID: 9506349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients.
    Yang DW; Zhang Y; Hong QY; Hu J; Li C; Pan BS; Wang Q; Ding FH; Ou JX; Liu FL; Zhang D; Zhou JB; Song YL; Bai CX
    Cancer; 2015 Sep; 121 Suppl 17():3113-21. PubMed ID: 26331818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated time-resolved immunofluorometric assay for progastrin-releasing peptide.
    Nordlund MS; Warren DJ; Nustad K; Bjerner J; Paus E
    Clin Chem; 2008 May; 54(5):919-22. PubMed ID: 18443179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients.
    Yashi M; Muraishi O; Kobayashi Y; Tokue A; Nanjo H
    Prostate; 2002 May; 51(2):84-97. PubMed ID: 11948963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated plasma concentrations of C-flanking gastrin-releasing peptide in small-cell lung cancer.
    Holst JJ; Hansen M; Bork E; Schwartz TW
    J Clin Oncol; 1989 Dec; 7(12):1831-8. PubMed ID: 2555450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer.
    Yamaguchi H; Soda H; Kitazaki T; Nakano H; Fujino S; Nakamura Y; Kohno S
    Respirology; 2007 Jan; 12(1):137-9. PubMed ID: 17207039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYFRA 21-1 and ProGRP, tumor markers of lung cancer, are elevated in chronic renal failure patients.
    Nakahama H; Tanaka Y; Fujita Y; Fujii M; Sugita M
    Respirology; 1998 Sep; 3(3):207-10. PubMed ID: 9767622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Sensitive Immunoelectrochemical Measurement of Lung Cancer Tumor Marker ProGRP Based on TiO₂-Au Nanocomposite.
    Wei Z; Cai X; Zhang J; Fan J; Xu J; Xu L
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30781735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.